|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.94 USD | -0.81% |
|
+3.47% | +1.84% |
| 02/12 | Bristol-Myers' Bid to Dismiss Lawsuit Related to Celgene Acquisition Rejected by US Judge | MT |
| 06/11 | The Market Can't Make Up Its Mind |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 12.92x | 1.18x | -12.62x | - | - | - | 1.41% | 873.02Cr | ||
| 6.52x | 0.65x | 1.25x | - | - | - | 4.75% | 38TCr | ||
| 19.39x | 2.98x | 2.15x | - | - | - | 0.89% | 11TCr | ||
| 14.59x | 1.43x | 0.66x | - | - | - | 4.75% | 7.07TCr | ||
| 5.82x | 0.54x | 3.29x | - | - | - | 5.1% | 6.23TCr | ||
| 17.8x | 3.62x | 3.74x | - | - | - | 3.71% | 6.13TCr | ||
| 7.22x | 0.7x | 0.71x | - | - | - | 6.92% | 5.91TCr | ||
| 6.45x | 0.58x | -40.54x | - | - | - | 4.72% | 5.82TCr | ||
| 10.49x | 1.66x | 3.95x | - | - | - | 4.01% | 4.56TCr | ||
| 13.2x | 1.52x | 1.37x | - | - | - | 3.39% | 3TCr | ||
| 9.57x | - | 0.28x | - | - | - | 3.99% | 2.98TCr | ||
| 5.44x | 0.41x | 1.27x | - | - | - | 5.39% | 2.9TCr | ||
| 9.46x | 1.67x | 0.79x | - | - | - | 6% | 2.65TCr | ||
| 5.94x | 0.3x | 1.1x | - | - | - | 5% | 2.47TCr | ||
| 6.36x | 0.75x | 0.52x | - | - | - | 4.83% | 2.01TCr | ||
| 5.84x | 0.56x | 1.21x | - | - | - | 5.1% | 1.97TCr | ||
| 5.56x | 0.83x | 2.31x | - | - | - | 4.48% | 1.6TCr | ||
| 9.31x | 1.32x | -3.21x | - | - | - | 4.15% | 1.49TCr | ||
| Average | 9.55x | 1.22x | -1.76x | 4.37% | 5.9TCr | ||||
| Weighted average by Cap. | 9.58x | 1.22x | -0.85x | 4.36% |
- Stock Market
- Equities
- UMBF Stock
- Sector UMB Financial Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















